Tofacitinib Linked to Higher Risk of Major Adverse Cardiac Events in People with Rheumatoid Arthritis Medicine & Technology Nov 11, 2021 Data recently showed that Tofacitinib is linked to statistically higher cases of major adverse cardiac events compared to TNF inhibitors, in people suffering from rheumatoid arthritis at an increased risk of cardiac occurrences.
TECH & INNOVATION OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts